FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Noma patents



      
           
This page is updated frequently with new Noma-related patent applications. Subscribe to the Noma RSS feed to automatically get the update: related Noma RSS feeds. RSS updates for this page: Noma RSS RSS


Date/App# patent app List of recent Noma-related patents
04/30/15
20150121518
 Privileged analytics system patent thumbnailnew patent Privileged analytics system
A computer-implemented method for determining whether a computer network is compromised by unauthorized activity on the computer network. The computer-implemented method comprises identifying a behavioral anomaly of an entity on the computer network, classifying the anomaly as a system event based on an assigned score for the anomaly being at least at a predetermined score threshold, updating an incident based on at least one common parameter between the system event and other system events which comprise the incident, each system event of the incident including an assigned score from when the event was an anomaly, updating a system status based on at least the incident, and assigning a system status score to the system status, and, determining whether the system status score is at least at a predetermined threshold system status score indicating that the computer network may be compromised..
Cyber-ark Software Ltd.
04/30/15
20150121461
 Method and system for detecting unauthorized access to and use of network resources with targeted analytics patent thumbnailnew patent Method and system for detecting unauthorized access to and use of network resources with targeted analytics
Methods and systems are disclosed for detecting improper, and otherwise unauthorized actions, associated with network resources, the actions including access to the resource and activity associated with the resource. The unauthorized actions are detected by analyzing action data of user actions employing accounts managed by a privileged access management system and associated with a network resource against profiles and rules to discover anomalies and/or deviations from rules associated with the network resource or accounts..
Cyber-ark Software Ltd.
04/30/15
20150121160
 Systems and methods for detecting, correcting, and validating bad data in data streams patent thumbnailnew patent Systems and methods for detecting, correcting, and validating bad data in data streams
In one aspect, a computer system for managing occurrences of data anomalies in a data stream is provided. The computer system includes a processor in communication with the data stream.
General Electric Company
04/30/15
20150119850
 Maintenance of bronchial patency by local delivery of cytotoxic, cytostatic, or anti-neoplastic agent patent thumbnailnew patent Maintenance of bronchial patency by local delivery of cytotoxic, cytostatic, or anti-neoplastic agent
Methods for maintaining patency in a bronchus of a patient are presented. A catheter is positioned within the bronchus.
Mercator Medsystems, Inc.
04/30/15
20150119453
 Compositions and methods for the treatment of depression patent thumbnailnew patent Compositions and methods for the treatment of depression
The invention relates to the compounds of formula i or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula i, and methods for treating or preventing depression may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection.
04/30/15
20150119397
 Histone demethylase inhibitors patent thumbnailnew patent Histone demethylase inhibitors
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds.
Quanticel Pharmaceuticals, Inc.
04/30/15
20150118712
 Cell-directed synthesis of multifunctional nanopatterns and nanomaterials patent thumbnailnew patent Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
Aspects of the invention relate to the engineering of biological nanostructures and materials.. .
Massachusetts Institute Of Technology
04/30/15
20150118681
 Method for predicting prognosis of renal cell carcinoma patent thumbnailnew patent Method for predicting prognosis of renal cell carcinoma
In order to provide a method for detecting an unfavorable prognostic risk of renal cell carcinoma easily with quite high sensitivity and specificity, a methylome analysis was performed on normal renal tissues, and non-cancerous tissues and renal cell carcinomas derived from patients with renal cell carcinomas. The result revealed that it was possible to detect an unfavorable prognostic risk of renal cell carcinoma by detecting a dna methylation level at at least one cpg site of fam150a, grm6, znf540, zfp42, znf154, rims4, pcdhac1, khdrbs2, ascl2, kcnq1, prac, wnt3a, trh, fam78a, znf671, slc13a5, and nkx6-2 genes..
National Cancer Center
04/30/15
20150118245
 Predictive biomarkers for ctla-4 blockade therapy and for pd-1 blockade therapy patent thumbnailnew patent Predictive biomarkers for ctla-4 blockade therapy and for pd-1 blockade therapy
Biomarkers are described for predicting the efficacy, risk of relapse, risk of an immune related adverse event (irae), or combination thereof for a ctla-4 blockade treatment, such as ipilimumab, in a subject with melanoma. Biomarkers are also described for predicting the efficacy and clinical benefit for a pd-1 blockade treatment, such as a pd-1 blocking antibody, in a subject with melanoma..
H. Lee Moffitt Cancer Center And Research Institute, Inc.
04/30/15
20150118244
 Anti-tumor antibodies as predictive or prognostic biomarkers of efficacy and survival in ipilimumab-treated patients patent thumbnailnew patent Anti-tumor antibodies as predictive or prognostic biomarkers of efficacy and survival in ipilimumab-treated patients
Provided herein are prognostic and diagnostic methods and kits for use with the methods. For example, provided herein are methods for determining whether a subject having cancer will respond to a cancer treatment.
Bristol-myers Squibb Company
04/30/15
20150118169
new patent

Cosmetic compositions and methods


A cosmetic composition for topical application to skin is provided. The cosmetic composition includes vitamin b3 compound, a ricinoleate compound and a dermatologically acceptable carrier.
The Procter & Gamble Company
04/30/15
20150116146
new patent

Anomaly detection using an antenna baseline constraint


Systems and methods are provided for monitoring carrier phase anomalies in a range finding system. A relative carrier phase between first and second antennas is predicted as a function of a relative position between the two antennas.
Northrop Grumman Systems Corporation
04/30/15
20150116093
new patent

Chemical and physical sensing with a reader and rfid tags


A method of detecting a stimulus can include detecting an output from a radio frequency identification tag including a sensor. A smartphone-based sensing strategy can use chemiresponsive nanomaterials integrated into the circuitry of commercial near field communication tags to achieve non-line-of-sight, portable, and inexpensive detection and discrimination of gas phase chemicals (e.g., ammonia, hydrogen peroxide, cyclohexanone, and water) at part-per-thousand and part-per-million concentrations..
Massachusetts Institute Of Technology
04/30/15
20150115109
new patent

Wayside measurement of railcar wheel to rail geometry


Considerable damage to rails, wheels, and trucks can result from geometric anomalies in the wheelsets, rails, and truck hardware. A solution for identifying and quantifying geometric anomalies known to influence the service life of the rolling stock or the ride comfort for the case of passenger service is described.
International Electronic Machines Corporation
04/30/15
20150114707
new patent

Nano-copper solder for filling thermal vias


A method of and device for forming vias on an electronic board (such as a pcb board) comprises forming one or more holes on the electronic board, placing a nanomaterial inside the one or more holes, and forming one or more filled holes on the electronic board. The nanomaterial can be nanocopper, which can be either push/pull into the holes on the electronic board or a combination of push and pull.
Flextronics Ap, Llc
04/30/15
20150114646
new patent

Triggered heating of wellbore fluids by carbon nanomaterials


A method of triggering heating within a subterranean formation, that includes introducting a wellbore fluid containing a dispersed carbon nanomaterial into a wellbore through the subterranean formation; lowering a microwave or ultraviolet radiation source into the wellbore; and irradiating the wellbore with microwave or ultraviolet radiation, thereby increasing the temperature of the wellbore fluid and/or wellbore is disclosed.. .
M-i L.l.c.
04/30/15
20150114124
new patent

Apparatus and inspecting a laminated structure


Disclosed is an apparatus, method and system for inspecting structures, and more particularly for evaluating the condition of a structure. The disclosed nondestructive inspection testing method and apparatus enables an operator to assess the condition of a structure, such as a composite laminate part and determining the location and depth of anomalies.
The Boeing Company
04/23/15
20150112999

System and implementing a scalable data storage service


A system that implements a scalable data storage service may maintain tables in a non-relational data store on behalf of clients. The system may provide a web services interface through which service requests are received, and an api usable to request that a table be created, deleted, or described; that an item be stored, retrieved, deleted, or its attributes modified; or that a table be queried (or scanned) with filtered items and/or their attributes returned.
Amazon Technologies, Inc.
04/23/15
20150111969

J-series prostaglandin-ethanolamides as novel therapeutics


A pharmaceutical composition comprising the compound of formula (i), a pharmaceutical composition comprising anandamide (aea) and methods of using the same in the treatment of non-melanoma skin cancer (nmsc) and colorectal cancer.. .
04/23/15
20150111904

Pharmaceutical combination of mek inhibitor and b-raf inhibitors


A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or solvate thereof, with a b-raf inhibitor, particularly n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or b-raf is beneficial, eg. Melanoma..
Glaxosmithkline Llc
04/23/15
20150111250

Methods and compositions for modulating tumor cell activity


Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin..
National Research Council Of Canada
04/23/15
20150110777

Antibodies that recognize iapp


The invention provides monoclonal antibody 6b8 and related antibodies. The 6b8 antibody binds to an epitope within residues 3-12 of iapp.
Neotope Biosciences Limited
04/23/15
20150110776

Antibodies that recognize iapp


The invention provides monoclonal antibody 3h6 and related antibodies. The 3h6 antibody binds to an epitope within residues 28-36 of iapp.
Neotope Biosciences Limited
04/23/15
20150110357

Detecting multi-object anomalies utilizing a low rank sparsity model


Methods and systems for detecting anomalies in transportation related video footage. In an offline training phase, receiving video footage of a traffic location can be received.
Xerox Corporation
04/23/15
20150108391

Synthesis of magnetic carbon nanoribbons and magnetic functionalized carbon nanoribbons


Various embodiments of the present disclosure pertain to methods of making magnetic carbon nanoribbons. Such methods generally include: (1) forming carbon nanoribbons by splitting carbon nanomaterials; and (2) associating graphene nanoribbons with magnetic materials, precursors of magnetic materials, or combinations thereof.
William Marsh Rice University
04/16/15
20150106927

Real-time detection and classification of anomalous events in streaming data


A system is described for receiving a stream of events and scoring the events based on anomalousness and maliciousness (or other classification). The events can be displayed to a user in user-defined groupings in an animated fashion.
Ut-battelle, Llc
04/16/15
20150106870

Anomaly detection on web client


Embodiments for anomaly detection on a web client are generally described herein. A processor on the web client is monitored, where a web browser is installed on the web client, with the web browser arranged to render a web page, the web page including content originating from a plurality of origins.
04/16/15
20150106324

Contextual graph matching based anomaly detection


Contextual graph matching based anomaly detection may include evaluating computer-generated log file data to create a master directed graph that specifies known events and transitions between the known events. The master directed graph may be processed to determine a plurality of decomposed master graph walks.
Accenture Global Services Limited
04/16/15
20150106314

Method and constructing a dynamic adaptive neural network array (danna)


A circuit element of a multi-dimensional dynamic adaptive neural network array (danna) may comprise a neuron/synapse select input functional to select the circuit element to function as one of a neuron and a synapse. In one embodiment of a danna array of such circuit elements, (wherein a circuit element or component thereof may be analog or digital), a destination neuron may be connected to a first neuron by a first synapse in one dimension, a second destination neuron may be connected to the first neuron by a second synapse in a second dimension and, optionally, a third destination neuron may be connected to the first neuron by a third synapse.
University Of Tennessee Research Foundation
04/16/15
20150106310

Method and constructing a neuroscience-inspired artificial neural network


A method and apparatus for constructing a neuroscience-inspired dynamic architecture (nida) for an artificial neural network is disclosed. The method comprises constructing, in one embodiment, an artificial neural network embodiment in a multi-dimensional space in memory such that a neuron is connected by a synapse to another neuron.
University Of Tennessee Research Foundation
04/16/15
20150105929

Building energy management method and system


An energy management system within a building obtains energy usage data over several cycles to determine a minimum feasible load. The minimum feasible load corresponds to operational conditions of the building, such as occupied or unoccupied.
Trane U.s. Inc.
04/16/15
20150105441

Lim kinasemodulating agents for neurofibromatoses therapy and methods for screening for same


Disclosed herein are methods of treating a patient at risk of developing or having a neurofibromatosis or a sporadic schwannoma. In exemplary embodiments, the method involves administering to a subject in need an effective amount of a limk modulating agent.
University Of Central Florida Research Foundation, Inc.
04/16/15
20150105265

Methods to assess the likelihood of dysplasia or esophageal adenocarcinoma


In some embodiments, a method for aiding assessment of the likelihood of dysplasia or esophageal adenocarcinoma being present in a subject can include (a) providing an esophagal sample from said subject (b) determining the methylation status of (i) slc22a18, (ii) pigr, (iii) gja12 and (iv) rin2 in said sample wherein if 2 or more of said genes are methylated then an increased likelihood of presence of dysplasia or esophageal is determined. The invention also relates to apparatus for same..
Medical Research Council
04/16/15
20150104412

Materials and methods useful for affecting tumor cell growth, migration and invasion


It is disclosed herein that mir-221 and mir-222 down-regulate pten and timp3 tumor suppressors, resulting in trail resistance. The present invention provides research, diagnostic, and therapeutic tools and methods related to this discovery.
The Ohio State University
04/16/15
20150101407

Gravity transducer


An airborne gravity-based transducer is disclosed as two embodiments with similar physical structures but different operating principles. The first design includes a particle acting as an active interface characterized by internal vibrations relating to its de broglie wave, a resonant cavity for trapping the particle, and a phonon-wave source wherein the de broglie and phonon waves interact over a junction area.
Nxt Energy Solutions, Inc.
04/09/15
20150100698

Extensible mechanisms for workload shaping and anomaly mitigation


Techniques and mechanisms for servicing requests for utilization of resources within a computing environment. A request is received from a remote electronic computing device with a regulator agent.
Salesforce.com, Inc.
04/09/15
20150099762

Compounds as rearranged during transfection (ret) inhibitors


This invention relates to novel compounds which are inhibitors of the rearranged during transfection (ret) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of gastrointestinal sensitivity, motility and/or secretion and/or abdominal disorders or diseases and/or treatment related to diseases related to ret dysfunction or where modulation of ret activity may have therapeutic benefit including but not limited to all classifications of irritable bowel syndrome (ibs) including diarrhea-predominant, constipation-predominant or alternating stool pattern, functional bloating, functional constipation, functional diarrhea, unspecified functional bowel disorder, functional abdominal pain syndrome, chronic idiopathic constipation, functional esophageal disorders, functional gastroduodenal disorders, functional anorectal pain, inflammatory bowel disease, proliferative diseases such as non-small cell lung cancer, hepatocellular carcinoma, colorectal cancer, medullary thyroid cancer, follicular thyroid cancer, anaplastic thyroid cancer, papillary thyroid cancer, brain tumors, peritoneal cavity cancer, solid tumors, other lung cancer, head and neck cancer, gliomas, neuroblastomas, von hippel-lindau syndrome and kidney tumors, breast cancer, fallopian tube cancer, ovarian cancer, transitional cell cancer, prostate cancer, cancer of the esophagus and gastroesophageal junction, biliary cancer, adenocarcinoma, and any malignancy with increased ret kinase activity.. .
Glaxosmithkline Intellectual Property Development Limited
04/09/15
20150099737

Pyrrolopyrimidine compounds as inhibitors of cdk4/6


The invention is directed to novel pyrrolopyrimidine compounds of formula (1) wherein r1, r2y, r4, r8-r11, a and l are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are cdk4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by cdk4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer.
Novartis Ag
04/09/15
20150099662

Method for the urinary detection of bladder cancer


The invention relates to the diagnosis of bladder cancer and more specifically to the detection in urine samples of bladder carcinomas of the transitional type. The detection method according to the present invention enables, through the utilization of a dna chip designed for this purpose, to determine the grade of the detected tumors..
Array Genomics
04/09/15
20150098984

Nanolithography using light scattering from particles and its applications in controlled material release


The present disclosure provides hollow nanostructures, methods of forming thereof, and methods of delivery of further nanomaterials utilizing the hollow nanostructures. The hollow nanostructures can be formed by illuminating particles, such as spherical particles, to create a scattering pattern that can be captured on, for example, a photoresist.
North Carolina State University
04/09/15
20150098898

Pharmaceutical composition, method and kit for detecting human melanoma cells


The present disclosure is related to a pharmaceutical composition for detecting human melanoma cells, including: a liposome, a biomolecule having specificity for αvβ3 integrin and a radionuclide. The present disclosure also provides a method using the pharmaceutical composition for detecting human melanoma cells and a kit performing the method.
Institute Of Nuclear Energy Research Atomic Energy Council, Executive Yuan
04/09/15
20150098883

Application of lactam as solvent in nanomaterial preparation


The present invention disclosed use of lactam as a solvent in the preparation of nanomaterials by precipitation method, sol-gel method or high temperature pyrolysis. These methods are able to recycle lactam solvent, which meet requirements of environmental protection..
Shanghai Genius Advanced Material (group) Co., Ltd.
04/09/15
20150098492

Method and master clock for generating fail-silent synchronization messages


The invention relates to a method for generating fail-silent synchronisation messages in a distributed real-time system, wherein the method uses the following functional units: a satellite receiver (110) for receiving a time signal (s-signal) from a navigation satellite system, a precision reference clock (130), which generates an actual time signal (r-signal), a central computer (140), a monitor (120) and a data block (210) for storing configuration parameters, wherein the satellite receiver (110) periodically generates an s-signal, and wherein the reference clock (130) periodically produces an r-signal, wherein the nominal frequency and phase of the r-signal is identical to the frequency and phase of the s-signal, and wherein the difference between the nominal and actual r-signal is used in order to minimise this difference in the future, and wherein, in the normal case of the satellite receiver (110), the periodic synchronisation message (220), which is to be generated in accordance with the configuration parameters (210) by the central computer (140), is generated on the basis of the s-signal and the difference between the nominal and actual r-signal is used in order to adapt (preferably in the short term) the state and (preferably in the long term) the timing rate of the reference clock (130) to the s-signal, and wherein, in the case of an anomaly of the satellite receiver (110), the timing rate adaptation of the reference clock (120) is suspended, and wherein, in the case of a fault of the satellite receiver (110), the periodic synchronisation message (220), which is to be generated in accordance with the configuration parameters (210) by the central computer (140), is generated on the basis of the r-signal, and wherein the monitor (120) checks whether the transmission time contained in the synchronisation message matches the actual transmission time and the distance between two successive synchronisation messages (220) lies within an a priori fixed tolerance interval, and, if this is not the case, modifies the synchronisation message (220) in such a way that each receiver identifies the synchronisation message (220) as erroneous.. .
Fts Computertechnik Gmbh
04/02/15
20150096034

Determine anomalies in web application code based on authorization checks


Example embodiments disclosed herein relate to determining an anomaly of a missing authorization or inconsistent authorization in web application code. The web application code is analyzed to identify methods that have authorization checks associated and labeling the identified methods as related to authorization checks.
Hewlett-packard Development Company, L.p.
04/02/15
20150096022

Dynamically adaptive framework and classifying malware using intelligent static, emulation, and dynamic analyses


Techniques for malware detection are described herein. According to one aspect, control logic determines an analysis plan for analyzing whether a specimen should be classified as malware, where the analysis plan identifies at least first and second analyses to be performed.
04/02/15
20150095490

Online sparse regularized joint analysis for heterogeneous data


A method and system are provided for online sparse regularized joint analysis for heterogeneous data. The method generates a latent space model modeling a latent space in which correlation information is encoded for a plurality of heterogeneous data points at respective time instants, responsive to respective energy-preserving projections and structure-preserving projections of the data points in the latent space.
Nec Laboratories America, Inc.
04/02/15
20150095203

Method and system for detection of anomalies in a merchant cash payment flow


A method and system of detecting anomalies in cash flow to and from a merchant includes receiving records from sources of cash flow to and records of deposits of cash flow from the merchant. The records of cash flow to the merchant are preferably provided from external sources independent of the merchant operations.
Mastercard International Incorporated
04/02/15
20150095069

Algorithms to identify patients with hepatocellular carcinoma


A method for identifying patients with a high risk of liver cancer development includes receiving patient data describing a plurality of patients and executing a patient identification module on the patient data to identify at least some of the plurality of patients as having a high risk of developing liver cancer. The patient identification module is generated based on an application of machine learning techniques to a training data set, and the patient identification module is validated based on both the training data set and an external validation data set.
The Regents Of The University Of Michigan
04/02/15
20150095003

Device and detection and/or diagnosis of faults in a processes, equipment and sensors


Device and method for the detection and/or diagnosis of faults in a process, equipment and sensors used to measure and control variables of a process, either for single faults or multiple faults. The detection and/or diagnosis are performed on the basis of residual calculation between measured values and values calculated by a plurality of parallel linear models, built up from the existing correlations between the measured variables by the process sensors and by different equations that rule the process, such as mass and heat balances, quality relationships, etc.
Ypf TecnologÍa S.a.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Noma for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Noma with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         















0.3975

3394

3 - 0 - 72